Biotech News
Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results
investors.twistbioscience.com2026-05-06 14:56 EST
SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the first quarter fiscal 2026 ended December 31, 2025.